Age-structured modeling of COVID-19 dynamics: the role of treatment and vaccination in controlling the pandemic

J Math Biol. 2024 Dec 24;90(1):12. doi: 10.1007/s00285-024-02168-8.

Abstract

In addition to non-pharmaceutical interventions, antiviral drugs and vaccination are considered as the optimal solutions to control and eliminate the COVID-19 pandemic. It is necessary to couple within-host and between-host models to investigate the impact of treatment and vaccination. Hence, we propose an age-structured model, where the infection age is used to link the within-host viral dynamics and the disease dynamics at the population level. We conduct a detailed analysis of the local and global dynamics of the model, and the threshold dynamics are completely determined by the basic reproduction number R 0 . Thus, the disease-free equilibrium is globally asymptotically stable and the disease eventually dies out when R 0 < 1 ; the disease-free equilibrium is globally attractive when R 0 = 1 ; the disease is uniformly persistent, and the unique endemic equilibrium is globally asymptotically stable when R 0 > 1 . The numerical simulation quantitatively studies the impact of the within-host viral dynamics on between-host transmission dynamics. The results show that the combination of antiviral drugs and vaccines can play a key role in mitigating the spread of COVID-19, but it is challenging to eliminate COVID-19 alone. To achieve the complete elimination of COVID-19, we need highly effective antiviral drugs and near-universal vaccine coverage.

Keywords: Age-structured model; Parameter estimation; Stability; Treatment; Vaccination.

MeSH terms

  • Age Factors
  • Antiviral Agents / therapeutic use
  • Basic Reproduction Number* / statistics & numerical data
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19* / epidemiology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • COVID-19* / transmission
  • Computer Simulation*
  • Humans
  • Mathematical Concepts*
  • Models, Biological
  • Pandemics* / prevention & control
  • SARS-CoV-2* / immunology
  • Vaccination / statistics & numerical data

Substances

  • COVID-19 Vaccines
  • Antiviral Agents